Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3434865446cb768b1dc8dcb327ffb857 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L89-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2012-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f78daf73e85854af8730ecdb0ff111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be5b5deaf3d198e06faf4dabef7d137d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4df35e5491ca0ce580f0e9cb614d2429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa3073804e6c18b378dc30c6e3a20383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf3149d054909016a63cf6508ef4d41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dddf34fd13d148c278a2c5663a3a2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cabe0bb26ce2268dc3a971dc9040875 |
publicationDate |
2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2455441-A1 |
titleOfInvention |
USEFUL HYDROGEL AS AN INJECTABLE SUPPORT FOR APPLICATION IN CELL THERAPY AND AS A CONTROLLED DRUG RELEASE SYSTEM |
abstract |
Hydrogel useful as an injectable support for application in cell therapy and as a controlled drug delivery system. # The present invention relates to hydrogels generated? In situ ?, under physiological conditions, by chemical crosslinking of two elastin-type biopolymers by means of a? Click reaction. chemistry ?. These hydrogels are non-cytotoxic and biocompatible, so they can comprise cells and / or active ingredients and thus be used for the preparation of medications or as implants in tissue regeneration procedures. They are also applicable to the biocompatibilization and bioactivation of solid implants through their coating and as systems for the controlled release of drugs. |
priorityDate |
2012-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |